Intension and extension of minimal residual disease in acute leukemia
10.3760/cma.j.cn115356-20221019-00304
- VernacularTitle:急性白血病微小残留病概念的内涵和外延
- Author:
Yingjun CHANG
1
;
Xiaosu ZHAO
Author Information
1. 北京大学人民医院血液科 北京大学血液病研究所 国家血液系统疾病临床医学研究中心 造血干细胞移植治疗血液病北京市重点实验室，北京 100044
- Keywords:
Leukemia, acute;
Minimal residual disease;
Hematological malignancies;
Malignant tumor;
Individualized therapy
- From:
Journal of Leukemia & Lymphoma
2023;32(1):8-11
- CountryChina
- Language:Chinese
-
Abstract:
Minimal residual disease (MRD) has been used not only for relapse prediction, prognosis re-classification and directing pre-emptive therapy of patients with acute leukemia, but also in the field of therapy for patients with other hematological malignancies or solid tumors. A deep understanding of the intension and extension of MRD is important for exploring novel methods for accurate prediction of relapse and consummating the individualized intervention strategies for malignant tumors.
